Toronto - Delayed Quote CAD

Curaleaf Holdings, Inc. (CURA.TO)

11.77 -0.36 (-2.97%)

At close: October 30 at 4:00:00 PM EDT

Chart Range Bar

Loading chart for CURA.TO

Previous Close 12.13
Open 11.90
Bid 11.75 x --
Ask 11.76 x --
Day's Range 11.55 - 11.96
52 Week Range 7.77 - 20.92
Volume 158,133
Avg. Volume 350,780
Market Cap (intraday) 3.117B
Beta (5Y Monthly) 1.60
PE Ratio (TTM) --
EPS (TTM) -0.19
Earnings Date Nov 3, 2026
Forward Dividend & Yield -- (0.00%)
Ex-Dividend Date --
1y Target Est 18.11

Curaleaf Holdings, Inc. engages in the retail and wholesale of cannabis products in the United States and internationally. The company operates licensed cultivation; and pharma-grade cannabis processing and manufacturing facilities. It also supplies cannabis on a wholesale basis to Australia, New Zealand, the United Kingdom and various European countries, including Germany, Italy, Poland, the Czech Republic, Switzerland, Sweden and Norway. In addition, the company operates a medical cannabis clinic and holds a pharmacy license. It serves the medical and adult-use cannabis markets through retail and wholesale channels. The company is based in Stamford, Connecticut.

www.curaleaf.com

5,554

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Drug Manufacturers - Specialty & Generic

Industry

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

CURA.TO

12.42%

S&P/TSX Composite index (^GSPTSE)

11.78%

1-Year Return

CURA.TO

1.64%

S&P/TSX Composite index (^GSPTSE)

18.03%

3-Year Return

CURA.TO

9.29%

S&P/TSX Composite index (^GSPTSE)

88.90%

5-Year Return

CURA.TO

67.52%

S&P/TSX Composite index (^GSPTSE)

69.32%

Earnings Per Share

gaap GAAP

nongaap Normalized

gaap GAAP

nongaap Normalized

Revenue vs. Earnings

yearly Annual

quarterly Quarterly

yearly Annual

quarterly Quarterly

Q2 FY26

Revenue 340.1M

Earnings 12.51M

Profit Margin 3.68%

FY25

FY26

100M

200M

300M

-10.0%

0.0%

10.0%

20.0%

Analyst Price Targets

16.05

18.11 Average

11.77 Current

21.06 High

Analyst Recommendations

Strong Buy
Buy
Hold
Underperform
Sell

Latest Rating

Date 8/8/2024

Analyst Needham

Rating Action Reiterates

Rating Buy

Price Action Maintains

Price Target 6.25 -> 6.25

Valuation Measures

  
  
 Annual 

Market Cap
Enterprise Value
Trailing P/E
Forward P/E
PEG Ratio (current)
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue
Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

Profit Margin

-2.63%
Return on Assets (ttm)

0.32%
Return on Equity (ttm)

-2.35%
Revenue (ttm)

1.32B
Net Income Avi to Common (ttm)

-41.2M
Diluted EPS (ttm)

-0.19

Balance Sheet and Cash Flow

Total Cash (mrq)

94.59M
Total Debt/Equity (mrq)

128.51%
Levered Free Cash Flow (ttm)

103.06M

VRNO.NE

TSND.TO

GTII.CN

CL.CN

TLRY.TO

U.S. markets closed

Curaleaf Holdings, Inc. (CURA.TO)

6.71%

-19.49%

-17.75%

12.42%

1.64%

-67.52%

-79.24%

Curaleaf Holdings, Inc. Overview Drug Manufacturers - Specialty & Generic / Healthcare

Full Time Employees

Fiscal Year Ends

Sector

Industry

Recent News

Performance Overview

YTD Return

1-Year Return

3-Year Return

5-Year Return

Earnings Trends

Earnings Per Share

Revenue vs. Earnings

Analyst Insights

Analyst Price Targets

Analyst Recommendations

Latest Rating

Statistics

Valuation Measures

Financial Highlights

Profitability and Income Statement

Balance Sheet and Cash Flow

Company Insights

Research Reports

People Also Watch